IL15RA
Interleukin-15 receptor subunit alpha
Also known as: CD215, I15RA_HUMAN, IL-15RA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13261
- Gene
- IL15RA
- Ensembl
- ENSG00000134470
- Chromosome
- 10
- Canonical length
- 267 aa
- Protein class
- CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Vesicles,Plasma membrane,Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a cytokine receptor that specifically binds interleukin 15 (IL15) with high affinity. The receptors of IL15 and IL2 share two subunits, IL2R beta and IL2R gamma. This forms the basis of many overlapping biological activities of IL15 and IL2. The protein encoded by this gene is structurally related to IL2R alpha, an additional IL2-specific alpha subunit necessary for high affinity IL2 binding. Unlike IL2RA, IL15RA is capable of binding IL15 with high affinity independent of other subunits, which suggests distinct roles between IL15 and IL2. This receptor is reported to enhance cell proliferation and expression of apoptosis inhibitor BCL2L1/BCL2-XL and BCL2. Multiple alternatively spliced transcript variants of this gene have been reported.[provided by RefSeq, Apr 2010]
Canonical amino-acid sequenceUniProt
267 residues, UniProt reviewed canonical sequence.
>Q13261|IL15RA
1 MAPRRARGCR TLGLPALLLL LLLRPPATRG ITCPPPMSVE HADIWVKSYS LYSRERYICN
61 SGFKRKAGTS SLTECVLNKA TNVAHWTTPS LKCIRDPALV HQRPAPPSTV TTAGVTPQPE
121 SLSPSGKEPA ASSPSSNNTA ATTAAIVPGS QLMPSKSPST GTTEISSHES SHGTPSQTTA
181 KNWELTASAS HQPPGVYPQG HSDTTVAIST STVLLCGLSA VSLLACYLKS RQTPPLASVE
241 MEAMEALPVT WGTSSRDEDL ENCSHHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL15RA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- lung: 46 nTPM
- urinary bladder: 24 nTPM
- gallbladder: 22 nTPM
- liver: 21 nTPM
- lymph node: 20 nTPM
- adipose tissue: 20 nTPM
Single-cell type
- decidual stromal cells: 92 nCPM
- fibroblasts: 70 nCPM
- pancreatic acinar cells: 68 nCPM
- cholangiocytes: 63 nCPM
- vascular endothelial cells: 58 nCPM
- sertoli cells: 55 nCPM
Immune cell
- intermediate monocyte: 33 nTPM
- MAIT T-cell: 29 nTPM
- classical monocyte: 26 nTPM
- non-classical monocyte: 21 nTPM
- memory CD8 T-cell: 20 nTPM
- gdT-cell: 19 nTPM
Brain region
- medulla oblongata: 11 nTPM
- spinal cord: 9.1 nTPM
- thalamus: 9 nTPM
- pons: 8.8 nTPM
- hypothalamus: 8 nTPM
- cerebral cortex: 7.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.58
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.23
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway via JAK-STAT
- interleukin-15-mediated signaling pathway
- natural killer cell differentiation
- negative regulation of neuron projection development
- positive regulation of natural killer cell differentiation
- positive regulation of phagocytosis
- response to nutrient levels
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sushi/SCR/CCP domain
- Sushi/SCR/CCP superfamily
- Interleukin-15 receptor subunit alpha
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL15RA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL15RA as an antibody target. Whether an autoantibody or antibody against IL15RA could matter depends on whether native IL15RA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL15RA is annotated at the cell surface, where native IL15RA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL15RA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...